Groenwold, Rolf H H <br/><br/>
Balance measures for propensity score methods: a clinical example on beta-agonist use and the risk of myocardial infarction.  [electronic resource] 

 -  Pharmacoepidemiology and drug safety  Nov 2011 
 - 1130-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1099-1557 
<br/><br/><label>Standard No.: </label>10.1002/pds.2251  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Academic Medical Centers<br/>Administration, Inhalation<br/>Adrenergic beta-Agonists--therapeutic use<br/>Adult<br/>Aged<br/>Anti-Asthmatic Agents--therapeutic use<br/>Asthma--drug therapy<br/>Bias<br/>Cardiovascular Diseases--drug therapy<br/>Cohort Studies<br/>Comorbidity<br/>Computer Simulation--statistics & numerical data<br/>Confounding Factors, Epidemiologic<br/>Delayed-Action Preparations--therapeutic use<br/>Female<br/>Humans<br/>Hypertension--drug therapy<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--drug therapy<br/>Propensity Score<br/>Proportional Hazards Models<br/>Pulmonary Disease, Chronic Obstructive--drug therapy<br/>Randomized Controlled Trials as Topic<br/>Risk<br/>Statistics, Nonparametric